Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Johnson County Clintrials LLC

Neither a doctor nor a teaching hospital

Research payments

$8,881,023

416 payments

Through program year 2025, Johnson County Clintrials LLC is reported as receiving $8,881,023 in research payments, across 416 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $5,100,437 314
2024 Research $373,719 32
2023 Research $1,376,875 37
2022 Research $880,099 13
2021 Research $402,095 2
2020 Research $444,632 3
2019 Research $303,166 15

Breakdown

Who paid Research payments · program years 2019–2025
  1. Janssen Research & Development, LLC $3,263,972 52 payments
  2. Moderna TX, Inc. $3,224,660 282 payments
  3. Bavarian Nordic A/S $1,542,879 12 payments
  4. Pfizer Inc. $534,593 37 payments
  5. Novavax Inc $102,875 12 payments
  6. Hoffmann-La Roche Limited $100,918 5 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $73,944 13 payments
  8. Amgen Inc. $31,941 2 payments
  9. BioNTech SE $5,242 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. Wev-Mva-002 $1,475,091 9 payments
  2. A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2 $1,277,697 14 payments
  3. A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ?18 Years of Age for the Prevention of Acute Gastroenteritis $1,223,589 53 payments
  4. A Randomized, Double-blind, Crossover Phase 2 Study to Evaluate the Immunogenicity and Safety of an Ad26.RSV.preF-based Vaccine and Ad26.COV2.S, Administered Sequentially, in Adults Aged 18 to 59 Years $814,481 14 payments
  5. A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ?50 Years of Age $504,748 23 payments
  6. A Randomized, Double-blind, Placebo-controlled, First-in-human Phase 1/2a Study to Evaluate Safety, Reactogenicity and Immunogenicity of 2 Universal Influenza (Uniflu) Vaccine Components, INFLUENZA G1 mHA and Ad26.FLU.003, in Healthy Adults $466,490 18 payments
  7. A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health $444,632 3 payments
  8. A Phase 12 Randomized Observerblind Study to Evaluate the Safety Tolerability and Immunogenicity of A Modified Rna Vaccine Against Varicella Zoster Virus in Healthy Individuals $424,962 29 payments
  9. A Study of Modified mRNA Vaccines in Healthy Adults $352,450 38 payments
  10. A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ?50 Years of Age $250,873 42 payments
What the money was spent on Research payments · program years 2019–2025
  1. Other $73,944 13 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record